Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nor have I seen any mention of medical JV progress
If the word is spreading at all, it isn't happening nearly fast enough. Whatever sales and marketing initiatives that might have taken place have produced virtually no traction
Not to mention the almost two years old share count and structure.
I assume there are about 61mm shs out now
Much more realistic post than normal.
Kudos to you. Keep up with the reality.
And happy holidays and good health going forward to all...
Well said. The only sentence in the letter that was a potential positive of note was his assertion that fy3q2016 ending 3/31/16 would be cash flow positive. Not sure how that's going to happen or whether or not it is real free cash flow from operations, but it would be a positive milestone if achieved. One piece of good news seems to be that certain persons who have been awarded shares in the past for fundraising have not appeared recently receiving additional stock.
Patience is not a virtue here. The longer it takes mills & co. to scale, the more likely they are to fail
None of the aspects or initiatives have shown any concrete results in terms of serious scale relative to a $22mm market cap. So far, it's been all mañana and nothing suggesting meaningful revenue ramps
... After recently being #1 on the breakdown board...
Huge move is ongoing ... Down over 85% from the $3.15 peak about 55 weeks ago
Nothing could be further from the truth, or you're delusional, or both
Mgmt may well have good intentions, but does not have the depth to execute whatever plan it has in an expedient timely fashion
Succeeding via distracting by being always early and never in doubt
The simple math translates to $180mm mkt cap post pilot & muni, and $420mm post acculife. The only way to get to those valuations are monster increases in the top line. No such evidence exists thus far.
No it won't ...
... But the filings might
Please don't. Hubris and excessive expectations are not kind to stocks. It's amazing how many mgmts and shareholders don't understand the concept of under promise and over deliver. Hyping is hazardous to your health and wealth
$885mm market cap at $15/sh. Good luck
Once upon a time, the word most used in these open ended statements was soon. I don't see that as much now.
I don't think I'm missing anything. I talk with doctors who consult in that general monitoring field, so I have a very good grasp on what the realities are and aren't relative to many companies trying to grab market share in various niches of the wearables space. Some have excellent products and may well execute to the benefit of shareholders. Most will not prove capable of offering superior differentiated product and being able to execute in an increasingly inhospitable lending environment.
Maybe acculife will prove to be the happy exception to the rule, maybe not.
Meanwhile, someone - shade I believe - posited several weeks ago that acculife should somehow be compared to Fitbit, at least partly from a valuation disparity perspective. Fitbit shares were trading mid to high $30's at the time, and I said I was short from about $40. A secondary was priced last night at $29. 3mm shares were sold instead of intended 7mm. Stock is down another 6% or so in the low $27 range. Lesson... Whenever a so called investment banker or other paid optimist tries to sell you a story based on a discount valuation to an overpriced stock in an alleged peer group, run away.
This was post 24448 before the truth hater(s) hit
Well, at least that's less than the $10 and $20 per share targets by New Years Eve some unicorns were pushing back in early 2013, or over a $1 billion mkt cap.
What stock are u talking about?
The real question remains whether ecsl shareholders will receive one acculife share per ecsl share or a lesser % of a full share. Until then, no one can truthfully even begin to realistically value anything.
Presumably Sept 30 quarter financials will be filed tomorrow. Wonder if there will be any upticks compared to pitiful June 30 financials
Time will tell. IPO window closing rapidly and will go dormant when world equity markets accelerate towards much lower levels
More likely a spinoff. IPO window appears to be closing. Only the desperate will float shares and likely at large discounts to prior expectations. More companies pulling going public plans. CPI Card the latest casualty.
I would prefer both, and so would many others
I believe the correct word is undertaker
I reiterate this mgmt team is very thin with virtually no bench depth. Time is of the essence and mills et al are spread very thin as they try to execute in all areas critical to growing the top line and gross/operating margins quickly and keeping expenses in line to the point of no longer burning cash
$36mm Mkt cap for less than $1mm revs and a presumed joint venture partner generating no revenues
Agreed.
Presuming pilot/flying j does make the decision to roll out cyberfuels' product nationally - and I would expect the decision to go or no go will be made by October 1, do not expect the rollout to be swift. If it goes national, it will be many many months before the product is in most of the stores.
Yes, banker/salespeople are part of the key to ipo's, along with a private company willing to hire them and pay them outrageous fees. Bankers are anything but masters and mistresses of the universe. They care primarily about closing a transaction, not the value of the private company going public
Patience (presumably) is a virtue
You brought up FIT, not me. Please share with everybody on the board your understanding of what acculife's initial valuation range is likely to be. FIT's mkt cap is about $6.8 bil.
Going up hard? Surely you jest. The chart says otherwise
Bankers are just glorified salesmen, not experts as they would like us to believe. Their targets are not carved in stone. Like las Vegas oddsmakers, all they are attempting to do is find a clearing price that gets the ipo 'done' and their fees paid.
Tax loss selling is very real and is in play from labor day to new years eve. To deny that is to be in denial of financial markets reality
There are hundreds of great stories in OTC and pink sheet land. Fewer than 5% ever come close to reaching the promised land
Beware comparisons to overvalued stocks. FIT is a nice to have, not a gotta have, allegedly health related company and stock. Valuation is seriously excessive vs reality. It is just the latest in the fitness craze fad stocks that ultimately crashed and burned. I am short from $39.
A useful post for those new to the stock and even those who wish to catch up on various fundamentals. Charts continue to look ugly, and tax loss selling will put constant pressure on this stock for the next 3.5 months. Actual shs o/s as of 3/31/15 were 58,751,053, and that presumably will be updated to close to 60mm in 15 days.
From a specialty biotech analyst...
OncoGeneX (NASDAQ: OGXI) is another company with near-term catalysts that's declined with the market. The company has made excellent progress in working with the FDA for its lead cancer drug, custirsen. The FDA has accepted a change in the clinical trial that allows the company to use data in patients with a poor prostate cancer prognosis. Data from that trial are expected by the end of the year, followed by data for a lung cancer trial in the second half of next year. It is a buy up to $2.50.